![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FMC1 |
Gene summary for FMC1 |
![]() |
Gene information | Species | Human | Gene symbol | FMC1 | Gene ID | 154791 |
Gene name | formation of mitochondrial complex V assembly factor 1 homolog | |
Gene Alias | C7orf55 | |
Cytomap | 7q34 | |
Gene Type | protein-coding | GO ID | GO:0006629 | UniProtAcc | Q96HJ9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
154791 | FMC1 | HTA11_6818_2000001011 | Human | Colorectum | AD | 9.33e-07 | 3.93e-01 | 0.0112 |
154791 | FMC1 | LZE4T | Human | Esophagus | ESCC | 1.11e-12 | 2.46e-01 | 0.0811 |
154791 | FMC1 | LZE7T | Human | Esophagus | ESCC | 2.88e-08 | 5.98e-01 | 0.0667 |
154791 | FMC1 | LZE8T | Human | Esophagus | ESCC | 4.40e-07 | 1.75e-01 | 0.067 |
154791 | FMC1 | LZE20T | Human | Esophagus | ESCC | 2.54e-06 | 3.30e-01 | 0.0662 |
154791 | FMC1 | LZE22D1 | Human | Esophagus | HGIN | 4.31e-05 | 1.74e-01 | 0.0595 |
154791 | FMC1 | LZE24T | Human | Esophagus | ESCC | 3.93e-22 | 6.86e-01 | 0.0596 |
154791 | FMC1 | LZE21T | Human | Esophagus | ESCC | 5.37e-06 | 2.77e-01 | 0.0655 |
154791 | FMC1 | LZE6T | Human | Esophagus | ESCC | 5.03e-04 | 8.36e-02 | 0.0845 |
154791 | FMC1 | P5T-E | Human | Esophagus | ESCC | 1.66e-02 | -1.52e-01 | 0.1327 |
154791 | FMC1 | P8T-E | Human | Esophagus | ESCC | 1.66e-02 | -1.52e-01 | 0.0889 |
154791 | FMC1 | P10T-E | Human | Esophagus | ESCC | 1.78e-03 | -1.52e-01 | 0.116 |
154791 | FMC1 | P12T-E | Human | Esophagus | ESCC | 3.50e-02 | -1.52e-01 | 0.1122 |
154791 | FMC1 | P16T-E | Human | Esophagus | ESCC | 3.75e-03 | -1.52e-01 | 0.1153 |
154791 | FMC1 | P21T-E | Human | Esophagus | ESCC | 7.90e-03 | -1.52e-01 | 0.1617 |
154791 | FMC1 | P22T-E | Human | Esophagus | ESCC | 3.50e-02 | -1.52e-01 | 0.1236 |
154791 | FMC1 | P24T-E | Human | Esophagus | ESCC | 1.66e-02 | -1.52e-01 | 0.1287 |
154791 | FMC1 | P26T-E | Human | Esophagus | ESCC | 3.75e-03 | -1.52e-01 | 0.1276 |
154791 | FMC1 | P27T-E | Human | Esophagus | ESCC | 1.66e-02 | -1.52e-01 | 0.1055 |
154791 | FMC1 | P28T-E | Human | Esophagus | ESCC | 3.50e-02 | -1.52e-01 | 0.1149 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0009895 | Colorectum | AD | negative regulation of catabolic process | 124/3918 | 320/18723 | 1.66e-13 | 3.35e-11 | 124 |
GO:0016042 | Colorectum | AD | lipid catabolic process | 97/3918 | 320/18723 | 4.31e-05 | 7.56e-04 | 97 |
GO:0050673 | Colorectum | AD | epithelial cell proliferation | 119/3918 | 437/18723 | 8.75e-04 | 8.51e-03 | 119 |
GO:00098951 | Colorectum | SER | negative regulation of catabolic process | 84/2897 | 320/18723 | 3.93e-07 | 2.06e-05 | 84 |
GO:00160421 | Colorectum | SER | lipid catabolic process | 77/2897 | 320/18723 | 3.52e-05 | 9.18e-04 | 77 |
GO:000989520 | Esophagus | HGIN | negative regulation of catabolic process | 87/2587 | 320/18723 | 1.74e-10 | 1.68e-08 | 87 |
GO:0009895111 | Esophagus | ESCC | negative regulation of catabolic process | 201/8552 | 320/18723 | 3.88e-10 | 1.05e-08 | 201 |
GO:005067318 | Esophagus | ESCC | epithelial cell proliferation | 238/8552 | 437/18723 | 1.19e-04 | 8.20e-04 | 238 |
GO:005067817 | Esophagus | ESCC | regulation of epithelial cell proliferation | 206/8552 | 381/18723 | 5.51e-04 | 3.02e-03 | 206 |
GO:00700711 | Esophagus | ESCC | proton-transporting two-sector ATPase complex assembly | 12/8552 | 15/18723 | 7.31e-03 | 2.63e-02 | 12 |
GO:00160427 | Esophagus | ESCC | lipid catabolic process | 168/8552 | 320/18723 | 7.97e-03 | 2.84e-02 | 168 |
GO:00192168 | Esophagus | ESCC | regulation of lipid metabolic process | 172/8552 | 331/18723 | 1.20e-02 | 4.02e-02 | 172 |
GO:00443423 | Esophagus | ESCC | type B pancreatic cell proliferation | 15/8552 | 21/18723 | 1.54e-02 | 4.96e-02 | 15 |
GO:000989522 | Liver | HCC | negative regulation of catabolic process | 196/7958 | 320/18723 | 7.98e-12 | 3.35e-10 | 196 |
GO:00192162 | Liver | HCC | regulation of lipid metabolic process | 181/7958 | 331/18723 | 4.58e-06 | 5.79e-05 | 181 |
GO:001604221 | Liver | HCC | lipid catabolic process | 175/7958 | 320/18723 | 6.50e-06 | 7.88e-05 | 175 |
GO:0070071 | Liver | HCC | proton-transporting two-sector ATPase complex assembly | 12/7958 | 15/18723 | 3.56e-03 | 1.59e-02 | 12 |
GO:000989528 | Thyroid | HT | negative regulation of catabolic process | 50/1272 | 320/18723 | 2.72e-08 | 2.02e-06 | 50 |
GO:005067320 | Thyroid | HT | epithelial cell proliferation | 48/1272 | 437/18723 | 6.86e-04 | 7.77e-03 | 48 |
GO:005067820 | Thyroid | HT | regulation of epithelial cell proliferation | 43/1272 | 381/18723 | 7.38e-04 | 8.23e-03 | 43 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FMC1 | SNV | Missense_Mutation | novel | c.35G>C | p.Arg12Pro | p.R12P | Q96HJ9 | protein_coding | deleterious(0) | probably_damaging(0.958) | TCGA-C8-A27B-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
FMC1 | deletion | Frame_Shift_Del | novel | c.294delN | p.Gly99ValfsTer27 | p.G99Vfs*27 | Q96HJ9 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
FMC1 | SNV | Missense_Mutation | c.203N>A | p.Cys68Tyr | p.C68Y | Q96HJ9 | protein_coding | deleterious(0) | probably_damaging(0.971) | TCGA-G4-6628-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
FMC1 | SNV | Missense_Mutation | novel | c.82C>T | p.Pro28Ser | p.P28S | Q96HJ9 | protein_coding | tolerated(0.87) | benign(0.015) | TCGA-EY-A1GX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
FMC1 | SNV | Missense_Mutation | c.61N>G | p.Leu21Val | p.L21V | Q96HJ9 | protein_coding | tolerated(1) | benign(0) | TCGA-21-1070-01 | Lung | lung squamous cell carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
FMC1 | SNV | Missense_Mutation | c.178N>T | p.His60Tyr | p.H60Y | Q96HJ9 | protein_coding | tolerated(0.25) | possibly_damaging(0.548) | TCGA-46-3768-01 | Lung | lung squamous cell carcinoma | Male | <65 | III/IV | Chemotherapy | carboplatin | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |